2024-03-29T09:20:30Z
http://repoint.unil.ch/oaiprovider/
oai:serval.unil.ch:BIB_20830C9BB645
2024-03-23T01:58:03Z
serval:BIB_20830C9BB645
Anti-TNF Treatment for Extraintestinal Manifestations of Inflammatory Bowel Disease in the Swiss IBD Cohort Study.
10.1097/MIB.0000000000001109
28452862
000405611400016
Vavricka
S.R.
author
Gubler
M.
author
Gantenbein
C.
author
Spoerri
M.
author
Froehlich
F.
author
Seibold
F.
author
Protic
M.
author
Michetti
P.
author
Straumann
A.
author
Fournier
N.
author
Juillerat
P.
author
Biedermann
L.
author
Zeitz
J.
author
Misselwitz
B.
author
Scharl
M.
author
Heinrich
H.
author
Manser
C.N.
author
Safroneeva
E.
author
Raja Ali
R.A.
author
Rogler
G.
author
Schoepfer
A.M.
author
Greuter
T.
author
Swiss IBD Cohort Study Group
contributor
article
2017-07
2017-07
Inflammatory bowel diseases
1536-4844
1078-0998
journal
23
7
1174-1181
Adalimumab/therapeutic use
Adolescent
Adult
Aged
Arthritis/drug therapy
Arthritis/immunology
Arthritis/pathology
Certolizumab Pegol/therapeutic use
Child
Child, Preschool
Female
Follow-Up Studies
Humans
Immunosuppressive Agents/therapeutic use
Inflammatory Bowel Diseases/drug therapy
Inflammatory Bowel Diseases/immunology
Inflammatory Bowel Diseases/pathology
Infliximab/therapeutic use
Male
Middle Aged
Prognosis
Stomatitis, Aphthous/drug therapy
Stomatitis, Aphthous/immunology
Stomatitis, Aphthous/pathology
Tumor Necrosis Factor-alpha/immunology
Young Adult
eng
60_published
peer-reviewed
Publication types: Journal Article
Publication Status: ppublish